Supakarn Pongsatonwiwat, B. Chumworathayi, Chatuporn Duangkum
{"title":"Mode of Deliveries and Perinatal Outcomes in Prenatal COVID-19\nInfections","authors":"Supakarn Pongsatonwiwat, B. Chumworathayi, Chatuporn Duangkum","doi":"10.2174/0126667975291928240319083013","DOIUrl":null,"url":null,"abstract":"\n\nThe Royal Thai College of Obstetricians and Gynaecologists (RTCOG)\nclinical practice guideline (CPG) does not recommend elective Cesarean Section (CS) in case of\nprenatal maternal COVID-19 infections without obstetric indication. In Thailand, little is known\nabout the mode of deliveries and perinatal outcomes in the mentioned group of patients. Therefore,\nthis study aims to fill the gap in knowledge.\n\n\n\nThe objective of this study was to compare the mode of deliveries and perinatal outcomes\nbetween pregnant women, who were infected with COVID-19 and those who were without COVID-\n19 infection.\n\n\n\nThe retrospective cohort study was based on data retrieved between February 1st and\nMarch 31st, 2023. The primary data was collected between July 1st, 2021, and October 31st, 2022.\nWomen with COVID-19 infection were matched with the non-COVID-19 group in a 1:1 ratio by\ndate at antenatal care (± 7 days) and their gestational age (± 1 week). Comparison of maternal and\nperinatal outcomes was made by using chi-squared, Fisher’s exact, relative risk, and t-test as appropriate\nin STATA software version 10.0.\n\n\n\nA total of 252 participants were recruited in this study, with 126 patients in each group.\nDemographic data between the two groups were comparable except for previous CS. The CS rates in\nthe COVID-19 and non-COVID-19 groups were 46.03% and 30.95%, respectively, with p = 0.009.\nThe significantly increased relative risk of CS in COVID-19 was 1.49 (95%CI, 1.07 to 2.05, p =\n0.02). Eight women out of 126 had undergone CS with a “COVID-19 infection” indication (p =\n0.007). The length of the maternal hospital stay was comparable. No serious maternal complications\nwere observed. Perinatal outcomes were similar among the two groups, except for neonatal jaundice\n(p = 0.029), with no reports of COVID-19 infections in delivery-related personnel.\n\n\n\nPrenatal COVID-19 infections lead to an increase in CS rate, while perinatal morbidities\nwere comparable in both groups, with COVID-19 and non-COVID-19. The RTCOG’s CPG should\nbe modified.\n","PeriodicalId":10815,"journal":{"name":"Coronaviruses","volume":"118 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coronaviruses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0126667975291928240319083013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The Royal Thai College of Obstetricians and Gynaecologists (RTCOG)
clinical practice guideline (CPG) does not recommend elective Cesarean Section (CS) in case of
prenatal maternal COVID-19 infections without obstetric indication. In Thailand, little is known
about the mode of deliveries and perinatal outcomes in the mentioned group of patients. Therefore,
this study aims to fill the gap in knowledge.
The objective of this study was to compare the mode of deliveries and perinatal outcomes
between pregnant women, who were infected with COVID-19 and those who were without COVID-
19 infection.
The retrospective cohort study was based on data retrieved between February 1st and
March 31st, 2023. The primary data was collected between July 1st, 2021, and October 31st, 2022.
Women with COVID-19 infection were matched with the non-COVID-19 group in a 1:1 ratio by
date at antenatal care (± 7 days) and their gestational age (± 1 week). Comparison of maternal and
perinatal outcomes was made by using chi-squared, Fisher’s exact, relative risk, and t-test as appropriate
in STATA software version 10.0.
A total of 252 participants were recruited in this study, with 126 patients in each group.
Demographic data between the two groups were comparable except for previous CS. The CS rates in
the COVID-19 and non-COVID-19 groups were 46.03% and 30.95%, respectively, with p = 0.009.
The significantly increased relative risk of CS in COVID-19 was 1.49 (95%CI, 1.07 to 2.05, p =
0.02). Eight women out of 126 had undergone CS with a “COVID-19 infection” indication (p =
0.007). The length of the maternal hospital stay was comparable. No serious maternal complications
were observed. Perinatal outcomes were similar among the two groups, except for neonatal jaundice
(p = 0.029), with no reports of COVID-19 infections in delivery-related personnel.
Prenatal COVID-19 infections lead to an increase in CS rate, while perinatal morbidities
were comparable in both groups, with COVID-19 and non-COVID-19. The RTCOG’s CPG should
be modified.